PNCK
Summary: PNCK is a member of the calcium/calmodulin-dependent protein kinase family of protein serine/threonine kinases (see CAMK1; MIM 604998) (Gardner et al., 2000 [PubMed 10673339]).[supplied by OMIM, Mar 2008].
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
pregnancy up-regulated nonubiquitous CaM kinase | MIM:300680 | Ensembl:ENSG00000130822 | HGNC:HGNC:13415 | PA134988711 | Xq28 |
GO terms in PNCK
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
MF | IBA | GO:0004674 | protein serine/threonine kinase activity |
MF | IBA | GO:0004683 | calmodulin-dependent protein kinase activity |
MF | IBA | GO:0005516 | calmodulin binding |
MF | IEA | GO:0005516 | calmodulin binding |
MF | IEA | GO:0005524 | ATP binding |
BP | IBA | GO:0018105 | peptidyl-serine phosphorylation |
BP | IBA | GO:0018107 | peptidyl-threonine phosphorylation |
BP | IBA | GO:0035556 | intracellular signal transduction |
CC | IBA | GO:0005622 | intracellular |
CC | IEA | GO:0005634 | nucleus |
CC | IEA | GO:0005737 | cytoplasm |
Gene expression in normal tissue: PNCK
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in PNCK
Database | Pathway ID | Pathway Des. |
---|
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD524 | ISX-9 | 3 |
iGMDRD451 | Serdemetan | 1 |
iGMDRD300 | Tozasertib | 2 |
iGMDRD329 | Merck60 | 2 |
iGMDRD577 | BIX01294 | 3 |
iGMDRD506 | Fedratinib | 2 |
iGMDRD780 | PP-30 | 3 |
iGMDRD318 | PAC-1 | 6 |
iGMDRD226 | ML006 | 3 |
iGMDRD77 | Itraconazole | 2 |
iGMDRD294 | Batimastat | 2 |
iGMDRD782 | DC-45-A2 | 3 |
iGMDRD227 | Fatostatin A | 7 |
iGMDRD474 | Avrainvillamide | 3 |
iGMDRD494 | Neopeltolide | 6 |
iGMDRD781 | Sirolimus | 3 |
iGMDRD889 | Compound 7d-cis | 4 |
iGMDRD772 | BRD4770 | 3 |
iGMDRD148 | Pifithrin-mu | 3 |
iGMDRD48 | Dexamethasone | 5 |
iGMDRD126 | Tipifarnib | 5 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in PNCK